![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Marginal Zone Lymphoma - 27 Studies Found
Recruiting |
: Marginal Zone Lymphoma Cohort in Korea : Lymphoma, B-Cell, Marginal Zone : 2016-04-04 : Other: Rituximab Cohort observation study |
Recruiting |
: Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) :
|
Terminated |
: Salvage Therapy With High Dose Oral Clarithromycin in Relapsed or Refractory Extranodal Marginal Zone Lymphoma : Lymphoma : 2012-01-06 : Drug: clarithromycin, oral, high dose 2 g/day clarithromycin (once a day) for 14 days followed by 7 days |
Completed |
: Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia :
|
RECRUITING |
: FDG PET Evaluation for Marginal Zone Lymphoma and Its Prognostic Role : Marginal Zone Lymphoma : 2024-06-18 |
RECRUITING |
: MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) : Follicular Lymphoma and Marginal Zone Lymphoma : 2024-06-18 : 1000mg /dose for 12 cycles(28 days) and a total of 11 doses :the first Cycle(Day1,Day15), the 2nd-8th Cycles(Day 1 every cycle);the 9th-12nd Cycl |